Androgen deprivation use with external beam radiation for prostate cancer: Results from CaPSURE™

Journal of Urology

Volumn 174, Issue 5, 2005, Pages 1802-1807

  Park, Sangtae ^a   Meng, Maxwell V ^a   Elkin, Eric P ^a   Speight, Joycelyn L ^b   DuChane, Janeen ^c   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAP PHARMACEUTICAL PRODUCTS INC   (United States)

Author keywords

Androgen antagonists; Combined modality therapy; Prostate; Prostatic neoplasms; Radiotherapy

Indexed keywords

ANDROGEN; ANTIANDROGEN; DIETHYLSTILBESTROL; FINASTERIDE; GONADORELIN AGONIST; GONADORELIN DERIVATIVE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CONTROLLED STUDY; DATA BASE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 27544440100     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000177089.93728.20     Document Type: Article

References (20)

1. Huggins, C. and Hodges, C. V.: Studies on prostate cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res, 1: 293, 1941
2. Meng, M. V., Grossfeld, G. D., Sadetsky, N., Mehta, S. S., Lubeck, D. P. and Carroll, P. R.: Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology, suppl., 60: 7, 2002
3. Cooperberg, M. R., Grossfeld, G. D., Lubeck, D. P. and Carroll, P. R.: National practice patterns and time trends in androgen ablation for localized prostate cancer. J Natl Cancer Inst, 95: 981, 2003
4. Soloway, M. S., Pareek, K., Sharifi, R., Wajsman, Z., McLeod, D., Wood, D. P., Jr. et al: Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. J Urol, 167: 112, 2002
5. Schulman, C. C., Debruyne, F. M., Forster, G., Selvaggi, F. P., Zlotta, A. R. and Witjes, W. P.: 4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer. Eur Urol, 38: 706, 2000
6. Bolla, M., Gonzalez, D., Warde, P., Dubois, J. B., Mirimanoff, R. O., Storme, G. et al: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med, 337: 295, 1997
7. D'Amico, A. V., Manola, J., Loffredo, M., Renshaw, A. A., DellaCroce, A. and Kantoff, P. W.: 6-Month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA, 292: 821, 2004
8. Pilepich, M. V., Winter, K., John, M. J., Mesic, J. B., Sause, W., Rubin, P. et al: Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys, 50: 1243, 2001
9. Roach, M., 3rd, DeSilvio, M., Lawton, C., Uhl, V., Machtay, M., Seider, M. J. et al: Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol, 21: 1904, 2003
10. Hanks, G. E., Pajak, T. F., Porter, A., Grignon, D., Brereton, H., Venkatesan, V. et al: Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02. J Clin Oncol, 21: 3972, 2003
11. Lubeck, D. P., Litwin, M. S., Henning, J. M., Stier, D. M., Mazonson, P., Fisk, R. et al: The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology, 48: 773, 1996
12. Cooperberg, M. R., Broering, J. M., Litwin, M. S., Lubeck, D. P., Mehta, S. S., Henning, J. M. et al: The contemporary management of prostate cancer in the United States: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a national disease registry. J Urol, 171: 1393, 2004
13. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A. et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969, 1998
14. Meng, M. V., Elkin, E. P., Harlan, S. R., Mehta, S. S., Lubeck, D. P. and Carroll, P. R.: Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE. J Urol, 170: 2279, 2003
15. Pilepich, M. V., Krall, J. M., al-Sarraf, M., John, M. J, Doggett, R. L., Sause, W. T. et al: Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology, 45: 616, 1995
16. Pilepich, M. V., Caplan, R., Byhardt, R. W., Lawton, C. A., Gallagher, M. J., Mesic, J. B. et al: Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol, 15: 1013, 1997
17. Lawton, C. A., Winter, K., Byhardt, R., Sause, W. T., Hanks, G. E., Russell, A. H. et al: Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys, 38: 931, 1997
18. Lawton, C. A., Winter, K., Murray, K., Machtay, M., Mesic, J. B., Hanks, G. E. et al: Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys, 49: 937, 2001
19. Cooperberg, M. R., Park, S. and Carroll, P. R.: Prostate cancer 2004: insights from national disease registries. Oncol (Huntingt), 18: 1239, 2004
20. Granfors, T., Modig, H., Damber, J.-E. and Tomic, R.: Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study. J Urol, 159: 2030, 1998